Serotiny
San Francisco, US · 1 known investors
Serotiny designs cell therapies using custom software and lab techniques that allow it to design and test up to 10,000 therapeutic genes at once, aiming to speed up the discovery of treatments for cancers such as multiple myeloma, prostate cancer and lung cancer. The San Francisco-based company works upstream in the cell and gene therapy discovery process and was acquired by Johnson & Johnson.
AI & Machine LearningBiotechHealthtech
Founders & leadership
JF
Justin FarlowCo-founder
CF
Colin FarlowCo-founder
Investors · 1
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase I | 2016 | $150K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Serotiny do?
- Serotiny designs cell therapies using custom software and lab techniques that allow it to design and test up to 10,000 therapeutic genes at once, aiming to speed up the discovery of treatments for cancers such as multiple myeloma, prostate cancer and lung cancer. The San Francisco-based company works upstream in the cell and gene therapy discovery process and was acquired by Johnson & Johnson.
- Who founded Serotiny?
- Serotiny was founded by Justin Farlow, Colin Farlow.
- Who are Serotiny's investors?
- Serotiny's investors include +ND Capital.
- Where is Serotiny headquartered?
- Serotiny is headquartered in San Francisco, US.